FDA approves Lilly's Foundayo , the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions 01 April
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz plus Zepbound delivered superior efficacy for adults with psoriatic arthritis and obesity 28 March
